Aerobiotix, Inc. is a privately held company specializing in the development and manufacture of proprietary environmental management devices for use in institutional healthcare, home health, and commercial settings. Aerobiotix has developed a suite of novel technologies for efficient biological elimination of airborne viruses, bacteria and spores to optimize indoor environments.
One of our primary goals is to build awareness of the contribution of air quality issues to hospital acquired infections by health care stakeholders: administrators, payers, clinicians and patients.
We partner with health care facilities to evaluate air quality issues, set air quality targets, and prescribe appropriate solutions through careful cost/benefit analysis.
DESIGN & MANUFACTURE
We design and manufacture safe and effective devices to optimize healthcare environments. All of our products are built at our own facility in Ohio, so that we can ensure the highest standards of quality and performance.
Air Disinfection Filtration System
David Kirschman, M.D.
President and CEO
The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space.
Chief Financial Officer
Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting.
Director of Client Services
Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.
Charles Edmiston, PhD
Globally recognized leader in hospital acquired infections with over 300 publications and 400 invited lectures. For 15 years served as a consultant to the Food & Drug Administration as an expert on the infection control including as Chairman of the General Hospital & Personal Use Device Panel of the Medical Devices Committee. Consultant to the Hospital Infection Control Practice Advisory Committee (HICPAC) of the Centers of Disease Control. Emeritus Professor at Medical College of Wisconsin.
Javad Parvizi, MD
Global leader in surgical site infections. He has published over 550 scientific articles and has written 18 text books in related subjects including a definitive book on THE HIP and also on THE KNEE. He has received numerous awards from various societies and has received funding for his research from the National Institute of Health, Department of Defense, Orthopedic Research and Education Foundation, Musculoskeletal Transplant Foundation, Arthritis Foundation and numerous other funding bodies.
Former CEO of Association of Professionals in Infection Control (APIC), former VP for Infection Prevention at Becton Dickinson and Company, strong track record in enterprise-wide strategy development, portfolio optimization, market shaping, public policy approaches and design of public-private partnerships. Named one of the “100 Most Powerful People in Healthcare 2010” by Modern Healthcare Magazine for her influence in driving awareness of healthcare-associated infections (HAIs).
Sue Barnes, RN
Prior Corporate IP Director of national Kaiser. She is Board certified in Infection Control and Prevention and was granted the designation of Fellow of APIC in 2015. She served on the National APIC Board of Directors from 2010 to 2012. She has been in the field of Infection Prevention since 1989. She has participated in the development of a number of APIC guides and served as a speaker for organizations including AORN and APIC. In addition. Sue has been published in journals including AORN Journal, American Journal of Infection Control, the Joint Commission Source for Compliance Strategies and The Permanente Journal.
Barbara Soule, RN
Joint Commission for Hospital Accreditation consultant for Infection Prevention and Control Services including assessments, deep analysis of specific infection challenges, writing and editing, teaching, product development, and cost saving methods for infection prevention, infection control leadership.
Russ Nassof, JD
Mr. Nassof has been involved in the field of environmental and health risk consulting for over 25 years concentrating his work in the areas of industrial hygiene, microbial contamination, toxic tort risk management, insurance defense, and infection control. Many of his risk management programs have been adopted as underwriting standards by the insurance industry and are utilized as risk barometers to evaluate emerging environmental and health related issues.
Carolyn Twomy, BSN
VP of Clinical Research, Quality and Regulatory for Irrimax Corporation. Former Global Head of Clinical Service, Molnlyke Health Care. Carolyn is a published author and a frequent and respected speaker for conferences throughout Europe, the US and Asia-Pacific.
Craig Della Valle, MD
Chief of Adult Reconstructive Surgery, Professor of Orthopaedic Surgery, Rush University Medical Center. Dr. Della Valle is a busy clinician who specializes in primary and revision total joint arthroplasty. A respected researcher, he has more than 180 peer reviewed publications on topics including unicompartmental, primary and revision total knee arthroplasty as well as total hip arthroplasty, hip resurfacing and revision total hip arthroplasty.